Compare Peptide Therapy Clinics by Compound and Pharmacy
BPC-157, Ipamorelin, Sermorelin and PT-141 share a category, not an evidence base. Vial takes them one compound at a time: what the law allows, which pharmacy makes it, and whether a physician is meaningfully involved.
Peptides are not one treatment
The peptide market blurs several very different things together.
There are established prescription drugs. There are compounds prepared by licensed compounding pharmacies. And there are research chemicals sold online with disclaimers saying they are not for human use.
The names can look identical. The oversight is not.
That is why the right place to start is not with the clinic. It is with the compound.
What are you researching, and what is its actual regulatory status?
Start with the compound, then compare providers
Most people arrive here with a name already in mind.
Maybe it is BPC-157 for an injury. Ipamorelin for sleep or body composition. PT-141 for sexual health. The harder questions come next: Is there credible human evidence? Can a clinician legally prescribe it? Which pharmacy makes it? Is the product coming from a pharmacy at all?
Vial breaks those questions down one compound at a time, then shows which providers offer it.
Frequently asked questions
Are peptides legal?
Some are. Some are not. Some sit in a shifting middle. Certain peptide drugs are FDA-approved. Others may be prescribed and compounded under specific circumstances. Many popular compounds are sold as research chemicals despite not being approved for human use. The rules also move. FDA policy, shortage conditions and compounding restrictions can change what pharmacies are willing or legally able to prepare.
What is the difference between research chemicals and prescribed peptides?
A research chemical is sold for laboratory use. It is not supposed to be injected or taken as medicine. A prescribed peptide comes through a licensed clinician and a licensed pharmacy. That structure adds a prescription, pharmacy controls and some level of accountability. The compound name may be the same. The supply chain may be completely different.
How do I check a peptide provider's pharmacy?
Ask for the pharmacy's name before you pay. Then verify its state license, accreditation and enforcement history. Look for recalls, FDA warning letters or disciplinary actions where available. A provider that will not disclose the pharmacy is asking you to accept a supply chain you cannot see.
Which peptides are commonly offered?
BPC-157 and TB-500 are widely marketed for injury recovery. CJC-1295 and Ipamorelin are commonly sold for sleep, recovery and body composition. Sermorelin appears in growth-hormone protocols. PT-141 is generally offered for sexual health. Popularity is not proof. Evidence, FDA status and lawful compounding availability vary widely across these compounds, and marketing often moves faster than regulation.
What does a legitimate peptide protocol look like?
A clinician reviews your history, explains why the compound is being recommended and writes a prescription when appropriate. The provider names the pharmacy. The label identifies the compound and dose. There is a plan for follow-up, side effects and stopping treatment. That does not settle every question about effectiveness or long-term effects. It does establish who is accountable. The pressure point now is economic as much as medical: large drugmakers want tighter control, regulators want fewer harmful products in circulation, and independent pharmacies are fighting to preserve a lawful role in personalized medicine. Where that line gets drawn will decide which peptides remain available, and who gets to sell them.
Go deeper
Peptides providers scored by Vial
Sorted by Vial Score. Showing 10 of 254 providers. See all peptide providers →
All 254 peptides providers
The Vial Score reflects what Vial can verify from public federal and state records, provider disclosures, and accreditation databases. A high rating is not an endorsement, and Vial's verification is not a clinical recommendation. Scores are not a substitute for evaluating whether a specific protocol is appropriate for you. Last updated September 28, 2026. How Vial scores providers →